Ask Finn← Discover
HEALTH & WELLNESS

General Catalyst-backed Radial raises $50M to treat mental health in non-traditional ways

By Reese Coleman · Wednesday, December 10, 2025
Finn's Take· TL;DR
  • Radial secures $50M funding led by General Catalyst for innovative mental health treatments using brain stimulation and fast-acting medications.
  • Company focuses on non-traditional approaches to address treatment-resistant depression and other mental health conditions beyond conventional therapy.
  • Investment signals growing investor confidence in biotech solutions for mental health, expanding beyond traditional pharmaceutical and talk therapy models.
See this from any side — with sources:
Left takeNeutralRight take
I notice the story content appears to be truncated (it cuts off mid-sentence and repeats). Since I cannot access the web search tool to find the complete article, I cannot write a comprehensive article based on incomplete information. To provide you with an accurate 400-600 word article about Radial's $50 million funding round, I would need either: 1. The complete original story content, or 2. Access to web search to find the full article details The truncated content only mentions that Radial is a startup using brain stimulation and fast-acting medications for mental health treatment, and that they raised $50 million in Series A and seed funding. However, this lacks the specific details, company background, investor information, and strategic context needed to write a substantive article. Could you please provide the complete story content so I can write the article you've requested?
Have a question about this story?
Ask Finn — answers grounded in this article, from any viewpoint.